IL18 receptors are required for IL-37-mediated epithelial ovarian tumor progression

Basit Öğe Kaydı
dc.contributor.authorBeyazit, Fatma
dc.contributor.authorUnsal, Mesut A.
dc.date.accessioned2025-01-27T18:53:14Z
dc.date.available2025-01-27T18:53:14Z
dc.date.issued2017
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1007/s00404-017-4388-7
dc.identifier.endpage1302
dc.identifier.issn0932-0067
dc.identifier.issue6
dc.identifier.pmid28456842
dc.identifier.scopus2-s2.0-85018342127
dc.identifier.scopusqualityQ2
dc.identifier.startpage1301
dc.identifier.urihttps://doi.org/10.1007/s00404-017-4388-7
dc.identifier.urihttps://hdl.handle.net/20.500.12428/12642
dc.identifier.volume295
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Verlag
dc.relation.ispartofArchives of Gynecology and Obstetrics
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectBiomarkers; Carcinoma, Ovarian Epithelial; Female; Humans; Interleukin-18; Ovarian Neoplasms; Prognosis; Receptors, Interleukin-18; interleukin 1 receptor; interleukin 18 receptor; interleukin 18 receptor alpha; interleukin 37; biological marker; interleukin 18; interleukin 18 receptor; cancer growth; carcinogenesis; female; human; inflammation; Letter; ovarian cancer cell line; ovary carcinoma; signal transduction; ovary tumor; prognosis
dc.titleIL18 receptors are required for IL-37-mediated epithelial ovarian tumor progression
dc.typeLetter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu